High-Intensity Interval Training in Patients with Substance Use Disorder
Table 1
Patient characteristics and medical use.
TG ()
CG ()
Combined ()
Men/women ()
8/1
5/2
13/3
Age (yr)
33 ± 11
31 ± 8
32 ± 9
Height (cm)
177 ± 10
175 ± 10
176 ± 10
Weight (kg)
84.1 ± 14.9
87.9 ± 20.8
85.8 ± 17.2
Current smoker
8
6
14
Drug use debut (age)
15 ± 6
17 ± 4
16 ± 5
Duration of abuse (yr)
17 ± 8
12 ± 4
15 ± 7
Primary drug
Heroin
1
1
2
BZD, Sed, Hypn
1
1
2
Amphetamine
4
4
8
Cannabis
3
1
4
Secondary drug
Alcohol
2
0
2
Heroin
1
1
2
Opiates, painkillers
2
1
3
Amphetamine
1
0
1
Cannabis
3
5
8
Symptoms for medicine prescription:
ADHD
0
1
1
Allergies
1
2
3
Anxiety
2
1
3
Arthritis
0
1
1
Asthma/COPD
0
1
1
Depression
1
2
3
Epilepsy
0
1
1
Hypertension
3
1
4
Schizophrenia/bipolar
1
2
3
Substitutional treatment
1
1
2
Other
0
3
3
Data are presented as mean ± SD; TG: training group; CG: control group, Type of medication is reported on indication of symptoms according to common directory. The prescribed medicines in substitutional treatment are methadone and suboxone. Others: skin disorder, pain, and inflammation.
